Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ORETICYL 25

DESERPIDINE; HYDROCHLOROTHIAZIDE

Standard Dose
0.125MG;25MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ORETICYL 25 is listed in Drugs@FDA under application 012148 (NDA).

Marketing status: Discontinued Active ingredient DESERPIDINE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 0.125MG;25MG Sponsor ABBVIE Submission history Latest submission status date: 2001-09-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview ORETICYL 25 is listed in Drugs@FDA under application 012148 (NDA). Marketing status: Discontinued Active ingredient DESERPIDINE; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 0.125MG;25MG Sponsor ABBVIE Submission history Latest submission status date: 2001-09-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
ORETICYL 25 (DESERPIDINE; HYDROCHLOROTHIAZIDE) | Drug Monograph | MedicHelpline